SEC Form 4 · accession 0000907654-26-000051
Oruka Therapeutics, Inc. · ORKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samarth Kulkarni
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 3, 2026 · 4:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000907654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $55.23 | Jun 2, 2026 | A | 9,136 | A | — | Jun 1, 2036 | Common Stock | 9,136 | 9,136 | D |
Explanation of responses
- F1The option vests as to 1/12 of the underlying shares monthly from June 2, 2026.